Item 7.01 Regulation FD Disclosure.

Enochian Biosciences Inc., a Delaware corporation (the "Company"), today has made available an Investor Presentation at the H.C. Wainwright 23rd Annual Global Investment Conference, during which our Chief Executive Officer, Dr. Mark Dybul, participated in a webcast. The Investor Presentation is attached to this Current Report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.

The information included in this Item 7.01 and in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

The Company undertakes no duty or obligation to update or revise information included in this Report or the Exhibit.

Item 9.01 Financial Statements and Exhibits.






  (d)  Exhibits




EXHIBIT NO.     DESCRIPTION                 LOCATION
  99.1            Investor Presentation       Furnished herewith

© Edgar Online, source Glimpses